FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q4 EPS of $0.30, $0.59 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $42.1 million versus the consensus estimate of $28.61 million.
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
... More
